iconstar paper   Hepatitis C Articles (HCV)  
Back grey arrow rt.gif
 
 
GS-7977 HCV Transplant Studies
 
 
  An Open-Label Study to Explore the Clinical Efficacy of GS 7977 With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant
 
Study to Investigate GS-7977 and Ribavirin for 24 Weeks in Subjects With Recurrent Chronic HCV Post Liver Transplant
 
This study is currently recruiting participants. Verified November 2012 by Gilead Sciences

 
 
 
 
  iconpaperstack View Older Articles   Back to Top   www.natap.org